Yong He

Yong He


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2022 in European Radiology
Verified
Journal Article
Closed access
PDF file
CLChongjiao Li
Chongjiao Li
YTYueli Tian
Yueli Tian
JCJie Chen
Jie Chen
YJYaqun Jiang
Yaqun Jiang
ZXZejian Xue
Zejian Xue
YHYong He
Yong He

1 August 2023 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
JCJie Chen
Jie Chen
KXKui Xu
Kui Xu
CLChongjiao Li
Chongjiao Li
YTYueli Tian
Yueli Tian
LLLing Li
Ling Li
YHYong He
Yong He

20 February 2023 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
YJYaqun Jiang
Yaqun Jiang
BWBing Wen
Bing Wen
CLChongjiao Li
Chongjiao Li
YTYueli Tian
Yueli Tian
ZXZhiwei Xiao
Zhiwei Xiao
YHYong He
Yong He

7 March 2024 in Journal of Nuclear Medicine
Verified
Journal Article
Open access
PDF file
CLChongjiao Li
Chongjiao Li
QCQiongrong Chen
Qiongrong Chen
YTYueli Tian
Yueli Tian
JCJie Chen
Jie Chen
KXKui Xu
Kui Xu
YHYong He
Yong He
Fibroblast activation protein (FAP) is a promising diagnostic and therapeutic target in various solid tumors. This study aimed to assess the diagnostic efficiency of 68Ga-labeled FAP inhibitor (FAPI)–04 PET/CT for detecting lymph node metastasis in non–small cell lung cancer (NSCLC) and to investigate the correlation between tumor 68Ga-FAPI-04 uptake and FAP expression. Methods: We retrospectively enrolled 136 participants with suspected or biopsy-confirmed NSCLC who underwent 68Ga-FAPI-04 PET/CT for initial staging. The diagnostic performance of 68Ga-FAPI-04 for the detection of NSCLC was evaluated. The final histopathology or typical imaging features were used as the reference standard. The SUVmax and SUVmean, 68Ga-FAPI–avid tumor volume (FTV), and total lesion FAP expression (TLF) were measured and calculated. FAP immunostaining of tissue specimens was performed. The correlation between 68Ga-FAPI-04 uptake and FAP expression was assessed using the Spearman correlation coefficient. Results: Ninety-one participants (median age, 65 y [interquartile range, 58–70 y]; 69 men) with NSCLC were finally analyzed. In lesion-based analysis, the diagnostic sensitivity and positive predictive value of 68Ga-FAPI-04 PET/CT for detection of the primary tumor were 96.70% (88/91) and 100% (88/88), respectively. In station-based analysis, the diagnostic sensitivity, specificity, and accuracy for the detection of lymph node metastasis were 72.00% (18/25), 93.10% (108/116), and 89.36% (126/141), respectively. Tumor 68Ga-FAPI-04 uptake (SUVmax, SUVmean, FTV, and TLF) correlated positively with FAP expression (r = 0.470, 0.477, 0.582, and 0.608, respectively; all P ≤ 0.001). The volume parameters FTV and TLF correlated strongly with FAP expression in 31 surgical specimens (r = 0.700 and 0.770, respectively; both P < 0.001). Conclusion:68Ga-FAPI-04 PET/CT had excellent diagnostic efficiency for detecting lymph node metastasis, and 68Ga-FAPI-04 uptake showed a close association with FAP expression in participants with NSCLC. Visual Abstract

21 February 2023 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
LJLi Jinghua
Li Jinghua
XKXu Kui
Xu Kui
GDGuo Deliang
Guo Deliang
LBLiao Bo
Liao Bo
ZQZhu Qian
Zhu Qian
YYYufeng Yuan
Yufeng Yuan

8 August 2022 in International Immunopharmacology
Verified
Journal Article
Closed access
XZXiaoqi Zhou
Xiaoqi Zhou
GYGuangming Ye
Guangming Ye
YLYibing Lv
Yibing Lv
YGYanyan Guo
Yanyan Guo
XPXingfei Pan
Xingfei Pan
PLPing Lei
Ping Lei